- Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Breast cancer research and treatment. 2011 Academic Article GET IT
Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 87